Clinical Trial Material Facility at NRC Royalmount (Montréal, Québec)

The National Research Council of Canada (NRC) is proposing to construct the Clinical Trial Material Facility (CTMF) for the domestic production of clinical trial material for vaccines and other biological therapeutics. The facility will be constructed as a new annex connected to the existing building on NRC premises at 6100 Royalmount Avenue (Montréal, QC). Project works will include site preparation, excavation and backfilling, construction of the new annex, connections to existing site infrastructure, renovation of the existing building, and associated landscaping of the finished site.


Disclaimer

This map is for illustrative purposes. The markers represent the approximate locations based on available data. More than one marker may be identified for a given assessment.

 

Latest update

December 01, 2021 - The assessment decision statement has been issued to the proponent.

Key documents

Key documents
Document Number Document Title File Date
3 Notice of Determination - December 1, 2021
2 Clinical Trial Material Facility - Public Comments Invited - September 22, 2021

List all records

Contacts

National Research Council of Canada
Email: NRC.ImpactAssessment-Evaluationdimpact.CNRC@nrc-cnrc.gc.ca


  • Location

    • 6100 Royalmount Avenue (Montreal, QC) (Quebec)
  • Nature of Activity

    • Building and Property Development
  • Assessment Status

    Completed
  • Start Date

    2021-09-22
  • Proponent

    National Research Council of Canada
  • Authorities

    • National Research Council of Canada
  • Assessment Type

    Project on federal lands
  • Reference Number

    82868

Nearby assessments

..within 200 kilometres
Date modified: